BIOAGE LABS INC (BIOA) Institutional Ownership Changes & 13F Activity
BIOAGE LABS INC (BIOA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Mpm Bioimpact Llc, Balyasny Asset Management L.P., Cormorant Asset Management, Lp, Integral Health Asset Management, Llc, and Millennium Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +9,529 | — | 9,529 | $233.56K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +78,365 | — | 78,365 | $1.92M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +17,476 | +76.7% | 40,258 | $986.72K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -1,218 | -74.2% | 423 | $10.37K | Q2 2026 | Aug 24, 2026 |
| Stonepine Capital Management, Llc | Sell | -30,000 | -60.0% | 20,000 | $490.20K | Q2 2026 | Aug 17, 2026 |
| Mpm Bioimpact Llc | Buy | +1,667,661 | — | 1,667,661 | $40.87M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -624,687 | -47.1% | 702,858 | $17.23M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Sell | -500,000 | -17.3% | 2,390,605 | $58.59M | Q2 2026 | Aug 14, 2026 |
| Integral Health Asset Management, Llc | Buy | +300,000 | — | 300,000 | $7.35M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -207,842 | -48.3% | 222,621 | $5.46M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Sell | -200,000 | -40.0% | 300,000 | $7.35M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +200,000 | — | 200,000 | $4.90M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +196,347 | +319.2% | 257,855 | $6.32M | Q2 2026 | Aug 14, 2026 |
| Yiheng Capital Management, L.P. | Buy | +170,532 | — | 170,532 | $4.18M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Sell | -167,458 | -13.9% | 1,033,129 | $25.32M | Q2 2026 | Aug 14, 2026 |
| Squadron Capital Management Llc | Buy | +155,000 | — | 155,000 | $3.80M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +127,420 | — | 127,420 | $3.12M | Q2 2026 | Aug 14, 2026 |
| Sphera Funds Management Ltd. | Buy | +127,153 | +147.0% | 213,671 | $5.24M | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Buy | +125,517 | +37.1% | 464,171 | $11.38M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +114,331 | +73.1% | 270,769 | $6.64M | Q2 2026 | Aug 14, 2026 |
| Nextbio Capital Management Lp | Buy | +100,732 | — | 100,732 | $2.47M | Q2 2026 | Aug 14, 2026 |
| Diadema Partners Lp | Buy | +86,334 | +143.9% | 146,334 | $3.59M | Q2 2026 | Aug 14, 2026 |
| Birchview Capital, Lp | Buy | +69,000 | — | 69,000 | $1.69M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +61,380 | — | 61,380 | $1.50M | Q2 2026 | Aug 14, 2026 |
| Polar Capital Holdings Plc | Sell | -60,296 | -5.3% | 1,072,344 | $26.28M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +59,198 | — | 59,198 | $1.45M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +43,571 | +6.2% | 742,761 | $18.21M | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Sell | -43,038 | -10.2% | 377,085 | $9.24M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Buy | +40,342 | +5.7% | 752,153 | $18.44M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +26,975 | +39.9% | 94,656 | $2.32M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about BIOA activity
Which institutional owners are buying BIOA?
Institutional owners buying BIOA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BIOA activity?
"Buy" means an investor increased their reported position in BIOA compared to the prior reporting period. This reflects growing exposure to BIOAGE LABS INC (BIOA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BIOA increasing?
Institutional interest in BIOA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.